glp 1 for hypothyroidism The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Frontiers | Use of GLP-1

For clinicians caring for women with T2DM today: Individualize therapy: recognize that women may derive equal or greater weight benefits from GLP-1 therapy but may also face more GI adverse eventscounseling and slow up-titration can improve persistence

Strikingly, liraglutide retained its full antidepressant and anti-anxiety efficacy in these mice, proving that the psychiatric benefits do not require direct brain-receptor engagement

Hollenstein et al., 2014)

Role of GLP-1 Agonists and SGLT-2 on Diabetes and Kidney Disease Post Liver Transplant The emergence of Glucagon-like peptide-1 receptor (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT-2) inhibitors as glucose-lowering therapies has opened new therapeutic avenues for managing patients with diabetic kidney disease

The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place